Cargando…

Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors reduce blood pressure (BP) and renal and cardiovascular events in patients with type 2 diabetes through not fully elucidated mechanisms. Aim of this study was to investigate whether dapagliflozin is able to acutely modify systemic and renal vascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solini, Anna, Giannini, Livia, Seghieri, Marta, Vitolo, Edoardo, Taddei, Stefano, Ghiadoni, Lorenzo, Bruno, Rosa Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654086/ https://www.ncbi.nlm.nih.gov/pubmed/29061124 http://dx.doi.org/10.1186/s12933-017-0621-8

Ejemplares similares

Adipocytokine levels mark endothelial function in normotensive individuals
por: Solini, Anna, et al.
Publicado: (2012)

Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study
por: Bruno, R. M., et al.
Publicado: (2015)

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
por: Versari, Daniele, et al.
Publicado: (2009)

P2X(7) Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric Unit
por: Pasqualetti, Giuseppe, et al.
Publicado: (2017)

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial
por: Sposito, Andrei C., et al.
Publicado: (2021)

Arterial–ventricular coupling and parameters of vascular stiffness in hypertensive patients: Role of gender
por: Faconti, Luca, et al.
Publicado: (2017)

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
por: Aroor, Annayya R., et al.
Publicado: (2018)

Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas
por: Hanis, Craig L., et al.
Publicado: (2016)

Pressure-Corrected Carotid Stiffness and Young’s Modulus: Evaluation in an Outpatient Clinic Setting
por: van der Bruggen, Myrthe, et al.
Publicado: (2021)

Aortic propagation velocity does not correlate with classical aortic stiffness parameters in healthy individuals
por: Arı, Hatem, et al.
Publicado: (2017)

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure
por: Bao, Nandi, et al.
Publicado: (2023)

The effect of dapagliflozin treatment on epicardial adipose tissue volume
por: Sato, Takao, et al.
Publicado: (2018)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
por: Ulusan, Sebahat, et al.
Publicado: (2023)

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
por: Lee, Dustin M., et al.
Publicado: (2018)

Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
por: González-Clemente, José M., et al.
Publicado: (2022)

Evaluation of the ambulatory arterial stiffness index in lead-exposed workers
por: Karakulak, Uğur Nadir, et al.
Publicado: (2017)

Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry
por: Bruno, Rosa Maria, et al.
Publicado: (2014)

Association between triglyceride glucose index and arterial stiffness in Korean adults
por: Lee, Sang Bae, et al.
Publicado: (2018)

Stiffness memory of EA.hy926 endothelial cells in response to chronic hyperglycemia
por: Targosz-Korecka, Marta, et al.
Publicado: (2013)

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
por: Arow, M., et al.
Publicado: (2020)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021)

Intima media thickness, pulse wave velocity, and flow mediated dilation
por: Bruno, Rosa Maria, et al.
Publicado: (2014)

Effects of Dapagliflozin on Endothelial Dysfunction in Type 2 Diabetes With Established Ischemic Heart Disease (EDIFIED)
por: Zainordin, Nur Aisyah, et al.
Publicado: (2019)

High glucose mediates endothelial-to-chondrocyte transition in human aortic endothelial cells
por: Tang, Rining, et al.
Publicado: (2012)

Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study
por: Wu, Shouling, et al.
Publicado: (2021)

Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
por: Lahnwong, Sarayut, et al.
Publicado: (2020)

Remote Ischemic Perconditioning Ameliorates Myocardial Ischemia and Reperfusion-Induced Coronary Endothelial Dysfunction and Aortic Stiffness in Rats
por: Szabó, Petra Lujza, et al.
Publicado: (2021)

Metabolic and Hormonal Determinants of Glomerular Filtration Rate and Renal Hemodynamics in Severely Obese Individuals
por: Vitolo, Edoardo, et al.
Publicado: (2016)

Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study
por: Junarta, Joey, et al.
Publicado: (2020)

Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus
por: Virdis, Agostino, et al.
Publicado: (2015)

Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
por: Aroor, Annayya R., et al.
Publicado: (2021)

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)
por: Kinguchi, Sho, et al.
Publicado: (2019)

Neurally mediated syncope: Is it really an endothelial dysfunction?
por: Dehghan, Bahar, et al.
Publicado: (2016)

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
por: Karg, M. V., et al.
Publicado: (2018)

Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells
por: Tang, Rining, et al.
Publicado: (2010)

Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study
por: Yan, Yu, et al.
Publicado: (2022)

Preeclampsia Is Associated with Increased Central Aortic Pressure, Elastic Arteries Stiffness and Wave Reflections, and Resting and Recruitable Endothelial Dysfunction
por: Torrado, Juan, et al.
Publicado: (2015)

Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus
por: Yue, Wen-Sheng, et al.
Publicado: (2011)

Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
por: Luo, Qianyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6htlnrqt08qvci071f0324qp37